1-9 of 9
Zvonko Milicevic
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes

Tim Heise, J. Hans DeVries, Shweta Urva, Jing Li, Edward J. Pratt, Melissa K. Thomas, Kieren J. Mather, Chrisanthi A. Karanikas, Julia Dunn, Axel Haupt, Zvonko Milicevic, Tamer Coskun
Journal: Diabetes Care
Diabetes Care 2023;46(5):998–1004
https://doi.org/10.2337/dc22-1710
Published: 01 March 2023
View articletitled, Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes
Open the PDF for Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes in another window
Journal Articles

Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)

Juan P. Frias, Enzo Bonora, Luis Nevarez Ruiz, Ying G. Li, Zhuoxin Yu, Zvonko Milicevic, Raleigh Malik, M. Angelyn Bethel, David A. Cox
Journal: Diabetes Care
Diabetes Care 2021;44(3):765–773
https://doi.org/10.2337/dc20-1473
Published: 04 January 2021
View articletitled, Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)
Open the PDF for Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11) in another window
Journal Articles

Assessment of Pancreas Safety in the Development Program of Once-Weekly GLP-1 Receptor Agonist Dulaglutide

Michael A. Nauck, Jean-Louis Frossard, Jamie S. Barkin, Greg Anglin, Ingrid E. Hensley, Kristine D. Harper, Zvonko Milicevic
Journal: Diabetes Care
Diabetes Care 2017;40(5):647–654
https://doi.org/10.2337/dc16-0984
Published: 10 March 2017
View articletitled, Assessment of Pancreas Safety in the Development Program of Once-Weekly GLP-1 Receptor Agonist Dulaglutide
Open the PDF for Assessment of Pancreas Safety in the Development Program of Once-Weekly GLP-1 Receptor Agonist Dulaglutide in another window
Includes: Supplementary data
Journal Articles

Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5). Diabetes Care 2014;37: 2149–2158

Michael Nauck, Ruth S. Weinstock, Guillermo E. Umpierrez, Bruno Guerci, Zachary Skrivanek, Zvonko Milicevic
Journal: Diabetes Care
Diabetes Care 2015;38(3):538
https://doi.org/10.2337/dc15-er03
Published: 12 February 2015
View articletitled, Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5). Diabetes Care 2014;37: 2149–2158
Open the PDF for Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5). Diabetes Care 2014;37: 2149–2158 in another window
Journal Articles

Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5)

Michael Nauck, Ruth S. Weinstock, Guillermo E. Umpierrez, Bruno Guerci, Zachary Skrivanek, Zvonko Milicevic
Journal: Diabetes Care
Diabetes Care 2014;37(8):2149–2158
https://doi.org/10.2337/dc13-2761
Published: 12 July 2014
View articletitled, Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5)
Open the PDF for Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5) in another window
Includes: Supplementary data
Journal Articles

Post Hoc Subgroup Analysis of the HEART2D Trial Demonstrates Lower Cardiovascular Risk in Older Patients Targeting Postprandial Versus Fasting/Premeal Glycemia

Itamar Raz, MD, Antonio Ceriello, MD, Peter W. Wilson, MD, Chakib Battioui, PHD, Eric W. Su, PHD, Lisa Kerr, MSPH, Cate A. Jones, PHD, Zvonko Milicevic, MD, Scott J. Jacober, DO
Journal: Diabetes Care
Diabetes Care 2011;34(7):1511–1513
https://doi.org/10.2337/dc10-2375
Published: 17 June 2011
View articletitled, Post Hoc Subgroup Analysis of the HEART2D Trial Demonstrates Lower Cardiovascular Risk in Older Patients Targeting Postprandial Versus Fasting/Premeal Glycemia
Open the PDF for Post Hoc Subgroup Analysis of the HEART2D Trial Demonstrates Lower Cardiovascular Risk in Older Patients Targeting Postprandial Versus Fasting/Premeal Glycemia in another window
Journal Articles

Effects of Prandial Versus Fasting Glycemia on Cardiovascular Outcomes in Type 2 Diabetes: The HEART2D trial

Itamar Raz, MD, Peter W.F. Wilson, MD, Krzysztof Strojek, MD, PHD, Irina Kowalska, MD, Velimir Bozikov, MD, PHD, Anselm K. Gitt, MD, György Jermendy, MD, Barbara N. Campaigne, PHD, Lisa Kerr, MSPH, Zvonko Milicevic, MD, Scott J. Jacober, DO
Journal: Diabetes Care
Diabetes Care 2009;32(3):381–386
https://doi.org/10.2337/dc08-1671
Published: 01 March 2009
View articletitled, Effects of Prandial Versus Fasting Glycemia on Cardiovascular Outcomes in Type 2 Diabetes: The HEART2D trial
Open the PDF for Effects of Prandial Versus Fasting Glycemia on Cardiovascular Outcomes in Type 2 Diabetes: The HEART2D trial in another window
Includes: Supplementary data
Journal Articles

Natural History of Cardiovascular Disease in Patients With Diabetes: Role of hyperglycemia

Zvonko Milicevic, MD, PHD, Itamar Raz, MD, Scott D. Beattie, PHD, Barbara N. Campaigne, PHD, Samiha Sarwat, MS, Elwira Gromniak, MD, Irina Kowalska, MD, Edvard Galic, MD, Meng Tan, MD, Markolf Hanefeld, MD, PHD
Journal: Diabetes Care
Diabetes Care 2008;31(Supplement_2):S155–S160
https://doi.org/10.2337/dc08-s240
Published: 01 February 2008
View articletitled, Natural History of Cardiovascular Disease in Patients With Diabetes: Role of hyperglycemia
Open the PDF for Natural History of Cardiovascular Disease in Patients With Diabetes: Role of hyperglycemia in another window
Journal Articles

Beyond Glycemia

Aaron I Vinik, MD, PHD, FACP, FCP, Zvonko Milicevic, MD, Gary L Pittenger, PHD
Journal: Diabetes Care
Diabetes Care 1995;18(7):1037–1041
https://doi.org/10.2337/diacare.18.7.1037
Published: 01 July 1995
View articletitled, Beyond Glycemia
Open the PDF for Beyond Glycemia in another window